https://www.selleckchem.com/pr....oducts/pf-07265807.h
rug action can help address common challenges in NE clinical trials and allow for faster selection and validation of promising therapies for more extensive investigation.BACKGROUND Necrotizing enterocolitis (NEC) develops through exaggerated toll-like receptor 4 (TLR4) signaling in the intestinal epithelium. Breast milk is rich in non-digestible oligosaccharides and prevents NEC through unclear mechanisms. We now hypothesize that the human milk oligosaccharides 2'-fucosyllactose (2'-FL) and 6'-sialyllactose (6'-SL) can reduce NEC th
Like
Comment
Share
